Conference
Study design of an efficacy and safety phase 3, randomized, double-blind, placebo-controlled trial of APL-130277 in the treatment of OFF episodes (CTH-300)
Authors
Olanow CW; Pappert E; Gardzinski P; Dzyngel B; Agro A
Volume
32
Publisher
WILEY
Publication Date
June 1, 2017
Name of conference
21st International Congress of Parkinson's Disease and Movement Disorders
Conference place
Vancouver, CANADA
Conference start date
June 4, 2017
Conference end date
June 8, 2017
Conference proceedings
MOVEMENT DISORDERS
ISSN
0885-3185